Connection

J. THORNTON to United States

This is a "connection" page, showing publications J. THORNTON has written about United States.
Connection Strength

0.466
  1. Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study. BMJ Open. 2024 May 30; 14(5):e082339.
    View in: PubMed
    Score: 0.069
  2. Patients' willingness to pay for naloxone: A national cross-sectional survey of prescription opioid users with chronic pain in the United States. J Am Pharm Assoc (2003). 2024 May-Jun; 64(3):102062.
    View in: PubMed
    Score: 0.067
  3. Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. J Occup Environ Med. 2024 Mar 01; 66(3):226-233.
    View in: PubMed
    Score: 0.066
  4. Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis. BMC Health Serv Res. 2023 Oct 31; 23(1):1185.
    View in: PubMed
    Score: 0.066
  5. Parents' intention to have their child vaccinated at a community pharmacy: A national cross-sectional survey. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):511-517.e8.
    View in: PubMed
    Score: 0.061
  6. Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use Disorder. J Pain Palliat Care Pharmacother. 2022 Jun; 36(2):103-111.
    View in: PubMed
    Score: 0.060
  7. Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
    View in: PubMed
    Score: 0.018
  8. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. Oncologist. 2024 Feb 02; 29(2):176-184.
    View in: PubMed
    Score: 0.017
  9. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC Cancer. 2023 Jul 13; 23(1):655.
    View in: PubMed
    Score: 0.016
  10. Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.
    View in: PubMed
    Score: 0.013
  11. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.